Where is Longas located?

Longas is headquartered in Sydney, Australia.

How many employees does Longas have?

As of Jul 01, 2024, the latest employee count at Longas is 5.

Where does Longas rank among its competitors?

Longas ranks 178th amongst 417 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Twin Strand Bio, which secured $5.66M in Feb, 2025.

Who are the top competitors of Longas?

Longas' top competitors include Nanopore Technologies, PacBio and DNAnexus. Among them, Twin Strand Bio secured the most recent funding round in February, 2025.

Longas - 2026 Company Profile, Team, Funding & Competitors

Company Details

Longas is the platform which provides next-generation sequencing. They have developed Morphoseq to deliver highly accurate long DNA sequences. With modest DNA input requirements and a standard short-read DNA sequencer, it can produce finished de novo genome assemblies, phase haplotypes, and more. They have a cloud-based end-to-end analysis pipeline. They use proprietary mutagenesis reaction to introduce unique mutation patterns into long DNA molecules.

Website: longastech.com
Social
Email ID: *****@longastech.com

Key Metrics

Founded Year

2015

Location

Sydney, Australia

Stage

Funding Raised

Investors

Brandon Capital

Ranked

178^th among 417 active competitors

Employee Count

5 as on Jul 01, 2024

Similar Companies

Nanopore Technologies & 476 more

View Longas' full profile

Longas is a funded company. Longas has 1 institutional investor.

View details of Longas's funding rounds and investors

The founders of Longas are Catherine Burke and Ian Charles. Nick McCooke is the CEO of Longas.

Here are the details of Longas' key team members:

Catherine Burke: Co-Founder of Longas.
Ian Charles: Co-Founder & Director of Longas.
Nick McCooke: CEO of Longas.

View details of Longas's Founder profiles and Board Members

Longas' employee count trend

Longas has 5 employees as of Jul 24. Here is Longas's employee count trend over the years:

Uncover Longas' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Longas include Nanopore Technologies, PacBio and DNAnexus. Here is the list of Top 10 competitors of Longas, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore Technologies 2005, Oxford (United Kingdom), Public	Manufacturer of portable and benchtop devices for real-time DNA sequencing	$1.34B	IP Group, GIC & 94 others	75/100
2nd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	72/100
3rd	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
4th	Fabric Genomics 2009, Oakland (United States), Acquired	AI-based disease diagnosis and genomic analysis tool for providers	$32.8M	UPMC, LDV Partners & 12 others	67/100
5th	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
6th	Twin Strand Bio 2015, Seattle (United States), Series B	Developer of DNA sequencing technology to identify genomic mutations	$84M	S32, Madrona & 9 others	66/100
7th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	General Atlantic, Lightspeed Venture Partners ... & 8 others	62/100
8th	S2 Genomics 2016, Livermore (United States), Acquired	Developer of automated sample preparation systems for genomics	$16M	Broadoak Capital Partners, RCT & 6 others	59/100
9th	Bionano 2002, San Diego (United States), Public	Provider of genome analysis solutions to researchers and clinicians	$124M	Battelle Ventures, Domain Associates & 17 others	58/100
10th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Jolt Capital, Debiopharm & 6 others	58/100
178th	Longas 2015, Sydney (Australia), Funding Raised	Platform for next-generation sequencing	-	Brandon Capital	25/100